290 related articles for article (PubMed ID: 25886680)
1. Psychotic disorders comorbid with attention-deficit hyperactivity disorder: an important knowledge gap.
Levy E; Traicu A; Iyer S; Malla A; Joober R
Can J Psychiatry; 2015 Mar; 60(3 Suppl 2):S48-52. PubMed ID: 25886680
[TBL] [Abstract][Full Text] [Related]
2. Attention-deficit hyperactivity disorder and comorbid psychosis: a review and two clinical presentations.
Pine DS; Klein RG; Lindy DC; Marshall RD
J Clin Psychiatry; 1993 Apr; 54(4):140-5. PubMed ID: 8098031
[TBL] [Abstract][Full Text] [Related]
3. [ADD psychosis: treatment with antipsychotics and methylphenidate?].
Blom JD; Kooij JJ
Tijdschr Psychiatr; 2012; 54(1):89-93. PubMed ID: 22237615
[TBL] [Abstract][Full Text] [Related]
4. Risk of Injury According to Attention Deficit Hyperactivity Disorder, Comorbid Mental Illness, and Medication Therapy.
Merrill RM; Thygerson SM; Palmer CA
Pharmacopsychiatry; 2016 Mar; 49(2):45-50. PubMed ID: 26829453
[TBL] [Abstract][Full Text] [Related]
5. First episode psychosis and comorbid ADHD, autism and intellectual disability.
Strålin P; Hetta J
Eur Psychiatry; 2019 Jan; 55():18-22. PubMed ID: 30384107
[TBL] [Abstract][Full Text] [Related]
6. Attention-deficit/hyperactivity disorder, methylphenidate use and the risk of developing schizophrenia spectrum disorders: A nationwide population-based study in Taiwan.
Shyu YC; Yuan SS; Lee SY; Yang CJ; Yang KC; Lee TL; Wang LJ
Schizophr Res; 2015 Oct; 168(1-2):161-7. PubMed ID: 26363968
[TBL] [Abstract][Full Text] [Related]
7. Tourette Syndrome and comorbid ADHD: current pharmacological treatment options.
Rizzo R; Gulisano M; Calì PV; Curatolo P
Eur J Paediatr Neurol; 2013 Sep; 17(5):421-8. PubMed ID: 23473832
[TBL] [Abstract][Full Text] [Related]
8. [Antipsychotic agents and stimulants: a judicious combination?].
de Jong MH; Eussen ML; van Gool AR
Tijdschr Psychiatr; 2010; 52(1):57-61. PubMed ID: 20054798
[TBL] [Abstract][Full Text] [Related]
9. Treatment with psychostimulants and atomoxetine in people with psychotic disorders: reassessing the risk of clinical deterioration in a real-world setting.
Corbeil O; Brodeur S; Courteau J; Béchard L; Huot-Lavoie M; Angelopoulos E; Di Stefano S; Marrone E; Vanasse A; Fleury MJ; Stip E; Lesage A; Joober R; Demers MF; Roy MA
Br J Psychiatry; 2024 Mar; 224(3):98-105. PubMed ID: 38044665
[TBL] [Abstract][Full Text] [Related]
10. Stimulant drug treatment in childhood-onset schizophrenia with comorbid ADHD: an open-label case series.
Tossell JW; Greenstein DK; Davidson AL; Job SB; Gochman P; Lenane M; Nugent Iii TF; Gogtay N; Sporn AL; Rapoport JL
J Child Adolesc Psychopharmacol; 2004; 14(3):448-54. PubMed ID: 15650502
[TBL] [Abstract][Full Text] [Related]
11. [Response to 'ADD psychosis: treatment with antipsychotics and methylphenidate?'].
Vergouwen T; Gorissen-Van Eenige M
Tijdschr Psychiatr; 2012; 54(3):308; author reply 309. PubMed ID: 22422425
[No Abstract] [Full Text] [Related]
12. Psychostimulants in the treatment of adults with psychosis and attention deficit disorder.
Opler LA; Frank DM; Ramirez PM
Ann N Y Acad Sci; 2001 Jun; 931():297-301. PubMed ID: 11462748
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic and psychostimulant drug combination therapy in attention deficit/hyperactivity and disruptive behavior disorders: a systematic review of efficacy and tolerability.
Linton D; Barr AM; Honer WG; Procyshyn RM
Curr Psychiatry Rep; 2013 May; 15(5):355. PubMed ID: 23539465
[TBL] [Abstract][Full Text] [Related]
14. Patterns of psychiatric comorbidity with attention-deficit/hyperactivity disorder.
Pliszka SR
Child Adolesc Psychiatr Clin N Am; 2000 Jul; 9(3):525-40, vii. PubMed ID: 10944655
[TBL] [Abstract][Full Text] [Related]
15. The use of psychostimulants in pervasive developmental disorders.
Abanilla PK; Hannahs GA; Wechsler R; Silva RR
Psychiatr Q; 2005; 76(3):271-81. PubMed ID: 16080422
[TBL] [Abstract][Full Text] [Related]
16. [Epilepsy and comorbid neurodevelopmental disorders].
Nordin V; Olsson IB; Tomson T
Lakartidningen; 2018 May; 115():. PubMed ID: 29786810
[TBL] [Abstract][Full Text] [Related]
17. ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines.
Kollins SH
J Atten Disord; 2008 Sep; 12(2):115-25. PubMed ID: 18192623
[TBL] [Abstract][Full Text] [Related]
18. [The psychopharmacology of the comorbid disorders associated with attention deficit hyperactivity disorder].
de la Osa-Langreo A; Mulas F; Téllez de Meneses M; Gandía R; Mattos L
Rev Neurol; 2007 Mar; 44 Suppl 2():S31-5. PubMed ID: 17347942
[TBL] [Abstract][Full Text] [Related]
19. Mixed Amphetamine Salts Without a Mood Stabilizer for Treating Comorbid Attention-Deficit Hyperactivity Disorder and Bipolar Disorder: Two Case Reports.
Armstrong C; Kapolowicz MR
Mil Med; 2023 May; 188(5-6):e1316-e1319. PubMed ID: 34318326
[TBL] [Abstract][Full Text] [Related]
20. Abuse liability of medications used to treat attention-deficit/hyperactivity disorder (ADHD).
Kollins SH
Am J Addict; 2007; 16 Suppl 1():35-42; quiz 43-4. PubMed ID: 17453605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
